Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$524 Sell
19
-457
-96% -$10.1K ﹤0.01% 4671
2026
Q1
$6.96K Buy
476
+370
+349% +$5.43K ﹤0.01% 3346
2025
Q4
$1.34K Buy
106
+35
+49% +$516 ﹤0.01% 3970
2025
Q3
$1.09K Buy
+71
New +$1.14K ﹤0.01% 3923
2025
Q2
Hold
0
3410
2025
Q1
Hold
0
3815
2024
Q4
Hold
0
3894
2024
Q3
Sell
-448
Closed -$11.7K 3426
2024
Q2
$11.7K Buy
448
+160
+56% +$3.33K ﹤0.01% 2288
2024
Q1
$6.3K Hold
288
﹤0.01% 2391
2023
Q4
$6.7K Hold
288
﹤0.01% 2324
2023
Q3
$5.68K Hold
288
﹤0.01% 2460
2023
Q2
$6.53K Sell
288
-210
-42% -$4.23K ﹤0.01% 2445
2023
Q1
$10.5K Sell
498
-351
-41% -$6.74K ﹤0.01% 2265
2022
Q4
$19K Buy
+849
New +$15.1K ﹤0.01% 2934

Other funds holding RXO

IFP Advisors's RXO Position: Q2 2026 in Review

IFP Advisors reduced its RXO (RXO) stake by 96% in Q2 2026, selling an estimated $10.1K and leaving 19 shares worth $524. The position accounts for ﹤0.01% of the portfolio, ranked #4671.

IFP Advisors first reported a position in RXO in Q4 2022 and has held it in 11 quarters since. The position peaked at $19K in Q4 2022. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • IFP Advisors held 19 shares of RXO worth $524 as of Q2 2026.
  • IFP Advisors sold 457 RXO shares in Q2 2026, an estimated $10.1K.
  • RXO made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4671 holding.
  • IFP Advisors first reported a position in RXO in Q4 2022 and has held it in 11 quarters since.
  • IFP Advisors's RXO position peaked at $19K in Q4 2022.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.